CAMBRIDGE, Mass., Oct. 14 /PRNewswire/ -- Dr. Peter Vajkoczy presented his latest patient data using the Bowman Perfusion Monitoring System(TM) to monitor absolute cerebral blood flow at a reception held by Hemedex(TM) Inc. of Cambridge, Massachusetts. Dr. Vajkoczy is a faculty member of The University of Heidelberg and member of the neurosurgical team at the Mannheim Medical Clinic in Mannheim, Germany. He has accumulated more experience with the Bowman Perfusion Monitoring System than anyone else in the world. His results support the use of the system to alert the medical staff in real time to the occurrence of vasospasm resulting from subarachnoid hemorrhage as well as in guiding the therapy of these patients. Dr. Vajkoczy also presented data demonstrating the benefit of the device in guiding the management of patients with traumatic brain injury. "We are very pleased with our early results from using the Bowman Perfusion System. I would use this technology in approximately one half of my brain-injured patients based on my initial experience. I am thrilled with the recent improvements that Hemedex has made to the device and I'm eager to begin using this latest product over the next several months," said Dr. Vajkoczy.
Studies suggest that 8-10 million Americans have brain aneurysms. About 20-30% of people with an aneurysm will have more than one. Each year, about 25,000-30,000 Americans suffer a rupture or break -- a condition known as subarachnoid hemorrhage.
At least 1.4 million people in the U.S. sustain a traumatic brain injury. Of them, approximately 50,000 die, 235,000 are hospitalized, 85,000 sustain permanent disability and the remainder are treated and released. At least 5.3 million Americans -- 2% of the U. S. population currently live with disabilities resulting from traumatic brain injury. The total annual cost of treatment and care of traumatic brain injury patients is over $56 billion.
Hemedex, Inc. was founded in 2000 to commercialize a proprietary platform technology conceived at the Massachusetts Institute of Technology (M.I.T.), for the purpose of measuring tissue perfusion (i.e., blood flow at the capillary level). This technology addresses high clinical need situations in complex medical and surgical procedures. These complex procedures often involve compromised vasculature and other serious pathophysiology, which results in high rates of morbidity, delayed recuperation, poor patient outcome and higher overall costs. The Company's patented technology provides clinicians with a powerful tool to generate valuable prognostic data, which can provide an early warning of impending tissue ischemia and help target appropriate therapies rapidly and accurately.
Hemedex's first product, the Bowman Perfusion Monitor(TM), which has been used successfully in neurosurgery, reconstructive surgery and organ transplantation clinical studies, provides a minimally invasive technique to accurately and continuously measure perfusion in small volumes of tissue. Prior to the Bowman system, the ability to get continuous, real time perfusion measurements in absolute units (ml/100g-min) did not exist. These measurements are a long sought after and important parameter in understanding and managing critical medical situations. Data from the Bowman Perfusion Monitor will help guide physicians in developing and implementing effective treatments quickly, creating the potential to improve patient outcomes and lower costs.
The Company's proprietary technology in the clinical application of thermal diffusion can be formulated to develop multiple products addressing unmet needs in many clinical areas such as neurosurgical monitoring, organ transplantation, cardiovascular monitoring, reconstructive surgery, critical care and endothelial function, among others.
Data Sources: emedicinehealth.com; The Center for Disease Control; The Traumatic Brain Injury Model Systems National Data Center
Contact Information: Hemedex, Inc. http://www.hemedex.com
Hemedex, Inc.CONTACT: Hemedex, Inc.: http://www.hemedex.com
Web site: http://www.hemedex.com//
